Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
暂无分享,去创建一个
J. Macías | J. Pineda | A. Rivero | L. López-Cortés | M. Márquez | F. Téllez | D. Merino | J. A. Mira | A. Torres-Cornejo | N. Merchante | M. J. Ríos-Villegas | J. Girón-González | I. de los Santos-Gil | I. Gea | A. Rivero-Juarez